Overview

A Relative Bioavailability Study of Two Formulations of BCX7353

Status:
Completed
Trial end date:
2017-09-30
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized study to investigate the relative bioavailability of two formulations of BCX7353 and to determine if there is a food effect
Phase:
Phase 1
Details
Lead Sponsor:
BioCryst Pharmaceuticals
Treatments:
Berotralstat